ACM
ANGO icon

Americafirst Capital Management’s AngioDynamics ANGO Stock Holding History

Americafirst Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-17,295
Closed -$292K – 162
2016
Q4 		$292K Sell
17,295
-86,156
-83% -$1.44M 0.31% 99
2016
Q3 		$1.81M Buy
+103,451
New +$1.68M 1.51% 6
2015
Q1 		– Sell
-35,183
Closed -$669M – 254
2014
Q4 		$669M Buy
+35,183
New +$596K 0.32% 91

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Americafirst Capital Management's ANGO Position: Q1 2017 in Review

Americafirst Capital Management sold out of AngioDynamics (ANGO) in Q1 2017, closing a stake of 17,295 shares — an estimated $292K sold.

Americafirst Capital Management first reported a position in ANGO in Q4 2014 and held it in 3 quarters. The position peaked at $669M in Q4 2014. 163 funds tracked by Wall St. Rank hold ANGO as of Q1 2017.

  • Americafirst Capital Management reported no remaining AngioDynamics position as of Q1 2017 after selling out during the quarter.
  • Americafirst Capital Management sold 17,295 AngioDynamics shares in Q1 2017, an estimated $292K.
  • Americafirst Capital Management first reported a position in AngioDynamics in Q4 2014 and held it in 3 quarters.
  • Americafirst Capital Management's AngioDynamics position peaked at $669M in Q4 2014.
  • 163 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2017.

Based on Americafirst Capital Management's 13F filing for Q1 2017, filed 17 Apr 2017.